Search results for "Nucleoside"

showing 10 items of 166 documents

The selective synthesis of metallanucleosides and metallanucleotides: a new tool for the functionalization of nucleic acids.

2012

Nucleobases team up: the efficient and selective preparation of purine-derived metallanucleosides, metallanucleotides, and metalladinucleotides having M-C bonds (M=Ir(III), Rh(III)) is reported for the first time. The results presented may be applied to the synthesis of functionalized nucleic acids, or DNA/RNA-modified segments.

Base pairMetalationchemistry.chemical_elementIridiumCatalysisNucleobaseRhodiumchemistry.chemical_compoundNucleic AcidsOrganic chemistryRhodiumBase PairingPurine NucleotidesBase SequenceChemistryOrganic ChemistryRNAGeneral ChemistryDNAPurine NucleosidesCombinatorial chemistryMetalsNucleic acidSurface modificationRNADNAChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

Variable presence of 5-methylcytosine in commercial RNA and DNA

2015

Nucleoside methylations and other nucleic acid modifications have recently encountered a surge in interest, prompted, among other things, by the detection of methylation and active demethylation of DNA and mRNA by similar mechanisms. In DNA, deoxycytidine methylation by Dnmt enzymes generates 5-methyldeoxycytidine,1 an important epigenetic mark that typically causes inactivation of transcription of the methylated promoter region. Recent exciting developments have shown that these marks are not concrete-cast, but can be actively removed by the oxidative action of TET enzymes,2 which generate, through a series of 2-electron oxidations, first hydroxymethylcytidine (hm5C), then formyldeoxycytid…

Bisulfite sequencingSaccharomyces cerevisiaeBiologyMass Spectrometrychemistry.chemical_compoundTranscription (biology)Escherichia coliMethylated DNA immunoprecipitationmodified nucleosideMolecular BiologyOligonucleotideRNADNACell BiologyRNA modificationMolecular biology5-MethylcytosinechemistryBiochemistry5-MethylcytosineNucleic acidRNADNA modificationDNAResearch PapermethylcytosineChromatography LiquidRNA Biology
researchProduct

The synergistic apoptotic effects of thiophenfurin, an inosine monophosphate dehydrogenase inhibitor, in combination with retinoids in HL60 cells

2006

New effective cytotoxic agents and combinations are urgently needed in cancer treatment. The enzyme inosine monophosphate dehydrogenase is a potentially useful target for drug development, since its activity has been shown to be amplified in malignant cells. Thiophenfurin, an inhibitor of the enzyme synthesized by us, is endowed with a significant apoptotic activity in promyelocytic leukaemia HL60 cells. Since retinoids were successfully employed in the treatment of patients with leukaemia, demonstrating significant differentiation-inducing and apoptotic effects, we carried out this study to evaluate the effects of the combination of thiophenfurin and several retinoid molecules, acting in d…

Cancer Researchmedicine.drug_classCellApoptosisHL-60 CellsTretinoinCell Growth ProcessesBiologyInosine Monophosphate Dehydrogenase InhibitorIMP DehydrogenaseIMP dehydrogenaseTretinoinAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansRetinoidEnzyme InhibitorsCytotoxicityMembrane Potential MitochondrialCell growthCell CycleDrug SynergismGeneral MedicineCell cycleMitochondriaenzymemedicine.anatomical_structureOncologyBiochemistryRibonucleosidesmedicine.drugOncology Reports
researchProduct

Absolute and relative quantification of RNA modifications via biosynthetic isotopomers

2014

In the resurging field of RNA modifications, quantification is a bottleneck blocking many exciting avenues. With currently over 150 known nucleoside alterations, detection and quantification methods must encompass multiple modifications for a comprehensive profile. LC-MS/MS approaches offer a perspective for comprehensive parallel quantification of all the various modifications found in total RNA of a given organism. By feeding (13)C-glucose as sole carbon source, we have generated a stable isotope-labeled internal standard (SIL-IS) for bacterial RNA, which facilitates relative comparison of all modifications. While conventional SIL-IS approaches require the chemical synthesis of single mod…

Carbon IsotopesTandem Mass SpectrometryEscherichia coli500 Natural sciences and mathematicsMethods OnlineRNANucleosides500 NaturwissenschaftenReference Standards13PseudouridineChromatography LiquidNucleic Acids Research
researchProduct

The Downside of an Effective cART: The Immune Restoration Disease

2013

The prognosis of patients infected with human immunodeficiency virus (HIV) type 1 has dramatically improved since the advent of the highly active antiretroviral therapy (HAART), which have enabled sustained suppression of HIV replication and recovery of CD4+ T cells count [1-3]. However, many patients in resource-poor settings still start HAART at a late stage of HIV infection when they already have advanced immunodeficien‐ cy [4,5]. Immune reconstitution in HIV infected patients is characterized by replenishment of immune cells depleted directly or indirectly by HIV infection, by regeneration of primary and secondary lymphoid organs, by restoration of pathogen-specific T, B and NK cells an…

CartSettore MED/17 - Malattie InfettiveNucleoside analoguebusiness.industryRegeneration (biology)HIV IRISDiseasemedicine.diseaseZidovudineImmune systemImmune reconstitution inflammatory syndromeDelayed hypersensitivityImmunologyMedicinebusinessmedicine.drug
researchProduct

Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver

1999

Zidovudine (3′-azido-2′,3′-dideoxythymidine [AZT]) inhibits human immunodeficiency virus replication and delays progression of acquired immune deficiency syndrome. We have recently found that, in muscle, AZT causes oxidative damage to mitochondrial DNA (mtDNA) and other signs of mitochondrial oxidative damage. The aim of this work was to test if AZT causes oxidative damage to liver mtDNA. In our study, an experimental mouse model was used in which mice were administered AZT (10 mg/kg body weight/d) in drinking water. Liver mtDNA of mice treated with AZT had 40% more of the oxidized, mutagenic nucleoside, 8-oxo-7,8-dihydroxy-2′deoxyguanosine (8-oxo-dG) than untreated controls. This oxidative…

ChemotherapyMitochondrial DNAHepatologyRatónvirusesmedicine.medical_treatmentvirus diseasesbiochemical phenomena metabolism and nutritionPharmacologyMitochondrionBiologyVirologyVirusZidovudineToxicitymedicineheterocyclic compoundsNucleosidemedicine.drugHepatology
researchProduct

Metabolomics of the effect of AMPK activation by AICAR on human umbilical vein endothelial cells

2011

AMP-activated protein kinase (AMPK) is a metabolic master switch expressed in a great number of cells and tissues. AMPK is thought to modulate the cellular response to different stresses that increase cellular AMP concentration. The adenosine analog, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) is an AMPK activator used in many studies to assess the effects of AMPK activation on cellular metabolism and function. However, the effect of AICAR on cell metabolism reaches many different pathways and metabolites, some of which do not seem to be fully related to AMPK activation. We have now for the first time used NMR metabolomics on human umbilical vein endothelial cells (HUVEC) fo…

Citric Acid CycleMetabolic networkAMP-Activated Protein KinasesBiologyUmbilical veinMetabolomicsHuman Umbilical Vein Endothelial CellsGeneticsmedicineHumansMetabolomicsProtein kinase ANuclear Magnetic Resonance BiomolecularCells CulturedPhospholipidsAnalysis of VarianceActivator (genetics)AMPKGeneral MedicineMetabolismAminoimidazole CarboxamideAdenosineCell biologyEnzyme ActivationBiochemistryMetabolomeRibonucleosidesGlycolysisMetabolic Networks and Pathwaysmedicine.drugInternational Journal of Molecular Medicine
researchProduct

Determination of queuosine derivatives by reverse-phase liquid chromatography for the hypomodification study of Q-bearing tRNAs from various mammal l…

2004

Three queuosine derivatives (Q-derivatives) have been found at position 34 of four mammalian so-called Q-tRNAs: queuosine (Q) in tRNA(Asn) and tRNA(His), mannosyl-queuosine (manQ) in tRNA(Asp), and galactosyl-queuosine (galQ) in tRNA(Tyr). An analytical procedure based on the combined means of purified tRNA isolation from liver cells and ribonucleoside analysis by reverse-phase high performance liquid chromatography coupled with real-time UV-spectrometry (RPLC-UV) was developed for the quantitative analysis of the three Q-derivatives present in total tRNA from liver tissues and liver cell cultures. Using this analytical procedure, the rates of Q-tRNA modification were studied in total tRNAs…

Clinical BiochemistryQueuosineRNA Transfer Amino AcylBiochemistryAnalytical Chemistrychemistry.chemical_compoundLiver Neoplasms ExperimentalRNA TransferNucleoside QTumor Cells CulturedAnimalsCells CulturedChromatography High Pressure LiquidChromatographyRNA Transfer AsnLiver cellRNAQueuineCell BiologyGeneral MedicineRibonucleosideRatsLiverchemistryBiochemistryCell cultureTransfer RNAHepatocytesHepatic stellate cellChickensJournal of Chromatography B
researchProduct

Synergistic effect of recombinant CD4-immunoglobulin in combination with azidothymidine, dideoxyinosine and 0.5 beta-monoclonal antibody on human imm…

1994

Data are presented which indicate that combinations of rCD4 immunoglobulin with azidothymidine, dideoxyinosine or 0.5 beta mouse monoclonal antibodies directed against the V3 region of HIV-1, were more effective in treatment of acute HIV infection in vitro than each compound alone. It is suggested that combination therapy with these compounds is more beneficial in treatment of HIV-infected patients than monotherapy, especially with respect to a reduction of the known side effects and the formation of resistant HIV strains after treatment with nucleoside analogues.

Combination therapymedicine.drug_classmedicine.medical_treatmentHIV InfectionsBiologyMonoclonal antibodyApplied Microbiology and BiotechnologyVirusZidovudinemedicineHumansLymphocytesCells Culturedvirus diseasesAntibodies MonoclonalDrug SynergismImmunotherapyVirologyIn vitroAnti-Bacterial AgentsDidanosinebiology.proteinDrug Therapy CombinationAntibodyNucleosideZidovudineCD4 Immunoadhesinsmedicine.drugLetters in applied microbiology
researchProduct

[Pharmacogenomics of antiretrovirals].

2008

HIV infection is a serious but treatable disease, yet current treatment is limited by development of resistance and high rates of adverse drug reactions. Antiretroviral therapy is especially suitable for pharmacogenomic investigation as both drug exposure and treatment response can be reliably measured. Increasing knowledge about genes implicated in pharmacokinetics, mode of action, efficacy, and toxicity of drugs has already provided relevant results for clinical practice, for example: The strong association of the abacavir hypersensitivity reaction with HLA-B*5701 permits testing patients for the allele, and if present avoiding the drug and therefore preventing the reaction. Persons with …

CyclopropanesDrugEfavirenzPyridinesmedia_common.quotation_subjectAtazanavir SulfateDiseaseBioinformaticsDrug HypersensitivityPatents as Topicchemistry.chemical_compoundPharmacokineticsCentral Nervous System DiseasesHLA AntigensAbacavirDrug Resistance ViralDrug DiscoveryMedicineHumansGenetic Predisposition to DiseasePharmacology (medical)Genetic TestingNevirapineGlucuronosyltransferaseDyslipidemiasHyperbilirubinemiamedia_commonRitonavirbusiness.industryPatient SelectionArea under the curveOxidoreductases N-DemethylatingGeneral MedicineDideoxynucleosidesBenzoxazinesHypersensitivity reactionCytochrome P-450 CYP2B6Infectious DiseaseschemistryAnti-Retroviral AgentsPharmacogeneticsAlkynesPharmacogenomicsAryl Hydrocarbon HydroxylasesbusinessOligopeptidesmedicine.drugMedicina clinica
researchProduct